{"title":"Six-months follow-up outcomes of COVID-19, comparison of ICU patients and non-ICU patients: a cohort study","authors":"Süleyman Yıldırım","doi":"10.14744/ejp.2022.7005","DOIUrl":"https://doi.org/10.14744/ejp.2022.7005","url":null,"abstract":"","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prognostic significance of pretreatment inflammatory response, immune and nutritional status in small cell lung cancer","authors":"Nuran Katgı","doi":"10.14744/ejp.2022.5004","DOIUrl":"https://doi.org/10.14744/ejp.2022.5004","url":null,"abstract":"","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Does the potential of functional capacity, fatigue and dyspnea change in the post-acute period according to the severity of COVID-19?","authors":"F. Yaman","doi":"10.14744/ejp.2022.1002","DOIUrl":"https://doi.org/10.14744/ejp.2022.1002","url":null,"abstract":"","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tele-pulmonary rehabilitation and remote assessment of exercise capacity","authors":"Ipek Candemir","doi":"10.14744/ejop_81_21","DOIUrl":"https://doi.org/10.14744/ejop_81_21","url":null,"abstract":"Tele-pulmonary rehabilitation (PR) is a good option for patients who underwent lung transplanta-tion or on the waiting list during the COVID-19 pandemic;in addition, optimum content, duration, and optimum remote assessment tests have not been defined for tele-PR. We reported our tele-PR model and two cases of exercise capacity, which were assessed remotely. Tele-PR can be effective in improving the exercise capacity in patients who underwent lung transplantation and in those who have advanced lung disorders and are on the waiting list for transplantation. Further-more, shuttle tests can be practical and convenient to use for remote assessment","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The disease history of patients with COPD","authors":"M. Süerdem","doi":"10.14744/ejp.2022.7002","DOIUrl":"https://doi.org/10.14744/ejp.2022.7002","url":null,"abstract":"","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Continuous Infusion of Ketamine for Adjunctive Analgosedation in Mechanically Ventilated Patients with Chronic Obstructive Pulmonary Disease","authors":"M. Haliloğlu","doi":"10.14744/ejp.2022.3005","DOIUrl":"https://doi.org/10.14744/ejp.2022.3005","url":null,"abstract":": BACKGROUND AND AIM: Ketamine is a fast-acting, hypnotic, amnestic agent that may be used to manage pain and agitation which is refractory to commonly used sedatives and analgesics. However, there is a paucity of literature describing the effects of continuous infusion of ketamine on sedative and analgesic consumption and delirium in mechanically ventilated patients. This investigation describes a single institution’s use of ketamine infusions as a part of a sedation protocol in the respiratory intensive care unit (RICU). METHODS: This was a retrospective cohort study of mechanically ventilated patients with chronic obstructive pulmonary disease (COPD) who received ketamine infusions as a part of a sedation protocol in a 16-bed RICU. The patients have assessed sedative consumption, analgesic consumption, and delirium incidence. RESULTS: A total of 100 COPD patients receiving ketamine continuous infusion as a part of a sedation protocol between November 2017 and April 2020 were eligible and enrolled in this study. We found that patients had a reduction in opioid and benzodiazepine requirements at 24, 48, and 72 h after ketamine initiation (p<0.05). In addition, significant reductions in vasopressor requirements were observed at 24, 48, and 72 h after ketamine initiation (p<0.05). During the analyzed time frame, all patients received ketamine infusion at 4 μg/kg/min. There were no reported adverse drug reactions. CONCLUSIONS: In this cohort of COPD patients who required mechanical ventilation we found decreased benzodiazepine, opiate, and vasopressor doses when the addition of a ketamine infusion, with no adverse drug reactions. Further prospective research is warranted to define optimal dosing strategies.","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"38 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of National Early Warning System-2 and quick Sepsis-related Organ Failure Assessment scores in predicting severe coronavirus disease 2019: a validation study","authors":"Mutlu Onur Gucsav","doi":"10.14744/ejp.2022.6002","DOIUrl":"https://doi.org/10.14744/ejp.2022.6002","url":null,"abstract":"BACKGROUND AND AIM: Coronavirus disease 2019 (COVID-19) has imposed a heavy burden on the intensive care unit and health care systems worldwide. Therefore, early detection of high-risk patients in terms of poor prognosis is crucial. We aimed to compare the diagnostic yield of the two most reliable scoring systems (National Early Warning Score 2 [NEWS 2] and quick Sepsis-related Organ Failure Assessment [qSOFA]) when repeatedly performed during the COVID-19 course. METHODS: The data of 403 COVID-19 patients admitted to our hospital between March 1, 2020, and November 30, 2020, were retrospectively reviewed. The demographic, comorbidity, and clinical data of the patients were recorded in the evaluation. NEWS2 and qSOFA score were retrospectively calculated at the time of admission, 24th hour, and 48th hour. We compared the effectiveness of qSOFA and NEWS2 for predicting the prognosis of COVID-19. RESULTS: The mean NEWS2 at the time of admission, 24th hour, and 48th hour was significantly higher in patients with poor outcomes than in patients with good outcomes. The 48th-hour NEWS2 was found to be the most successful score in predicting the poor outcome (AUC: 0.854;95% CI: 0.81-0.88;p<0.001). NEWS2 at 0th, 24th, and 48th hours were found to be superior to qSOFA scores at the same time points. CONCLUSIONS: NEWS2 was superior to qSOFA in determining the need for intensive care support and/or mortality. A high NEWS2 at the 48th hour seems to be more valuable to predict worse outcomes.","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unfamiliar territory of a familiar drug: INH-induced erythroderma","authors":"R. Kancherla","doi":"10.14744/ejp.2021.8321","DOIUrl":"https://doi.org/10.14744/ejp.2021.8321","url":null,"abstract":": Tuberculosis is a major cause of ill health, and one of the top ten causes of death worldwide. Treatment with multiple first-line drugs is the standard recommended treatment for drug-sensitive tuberculosis. Isoniazid (INH) is an important component of first-line therapy. Erythroderma is a rare but serious adverse drug reaction. We report here a case of a 64-year-old man who presented with generalized itchy, red-colored scaly lesions associated with extensive skin peeling after 8 weeks of antitubercular treatment (ATT). After the withdrawal of ATT, skin lesions improved along with symptomatic treatment. On sequential rechallenge with INH, the patient developed a recurrence of skin lesions, which confirmed the diagnosis of INH-induced erythroderma.","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67323980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ultrasound-guided pleural biopsy","authors":"Darryl P. Boy","doi":"10.14744/ejp.2021.9621","DOIUrl":"https://doi.org/10.14744/ejp.2021.9621","url":null,"abstract":": A pleural exudate that remains undiagnosed after a combined clinical assessment, thoracentesis, and imaging requires a pleural biopsy for a definitive diagnosis. Thoracoscopy is often the first method of choice to obtain tissue as it offers greater sensitivity and there is a perception of less risk. However, with imaging guidance, closed pleural biopsy is a safe, affordable, and effective alternative to diagnose all forms of pleural disease. Ultrasound (US) has several benefits when compared with computed tomography for image-guided biopsy, as it is widely available, can be performed bedside, and does not expose the patient to radiation. If performed in optimal conditions, a transthoracic US-guided closed pleural biopsy can yield results comparable to those of thoracoscopy and a marked reduction in the complication rate versus blind biopsy. Abrams and Tru-Cut needles are the most widely used for a closed pleural biopsy. Either may be used with real-time image guidance or with a free-hand image-assisted technique to harvest up to 6 separate tissue samples. The needle choice will depend on the morphology of the lesion observed on imaging. The Tru-Cut is generally preferred for mass lesions of the pleura or pleura that is >20 mm in thickness, and the Abrams for pleural thickening of <20 mm or radiologically normal pleura. A transthoracic US may be used to detect, rule out, and prevent complications, such as bleeding, solid organ injury, or pneumothorax. The ability to perform thoracic US is a necessary skill in current respiratory practice, and US-guided closed pleural biopsy has a critical role in diagnosis.","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"COVID 19, emphysema, and secondary pulmonary fibrosis: About a case report","authors":"Alejandro García-Cajiao","doi":"10.14744/ejop_76_21","DOIUrl":"https://doi.org/10.14744/ejop_76_21","url":null,"abstract":"Associations have been drawn between pre-existing diseases and adverse outcomes during the course of the ongoing coronavirus 2019 (COVID-19) pandemic, the disease resulting from in-fection with recently identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients who have chronic obstructive pulmonary disease with the emphysema-hyperinflated phenotype are one of the population groups with basal risk comorbidities who may have a higher probability of developing secondary pulmonary fibrosis, even in the early stages of COVID-19, potentially leading to permanent adverse functional consequences and even death. The aim of this report was to investigate this pathophysiological association in order to examine potential therapeutic targets for use during the COVID-19 pandemic that could reduce future sequelae using an illustrative clinical case and the available literature","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67324064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}